1. Home
  2. ATYR vs VPG Comparison

ATYR vs VPG Comparison

Compare ATYR & VPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATYR
  • VPG
  • Stock Information
  • Founded
  • ATYR 2005
  • VPG 2009
  • Country
  • ATYR United States
  • VPG United States
  • Employees
  • ATYR N/A
  • VPG N/A
  • Industry
  • ATYR Biotechnology: Biological Products (No Diagnostic Substances)
  • VPG Electrical Products
  • Sector
  • ATYR Health Care
  • VPG Technology
  • Exchange
  • ATYR Nasdaq
  • VPG Nasdaq
  • Market Cap
  • ATYR 306.2M
  • VPG 340.4M
  • IPO Year
  • ATYR 2015
  • VPG N/A
  • Fundamental
  • Price
  • ATYR $5.13
  • VPG $28.27
  • Analyst Decision
  • ATYR Strong Buy
  • VPG Hold
  • Analyst Count
  • ATYR 6
  • VPG 1
  • Target Price
  • ATYR $20.20
  • VPG $31.00
  • AVG Volume (30 Days)
  • ATYR 3.6M
  • VPG 154.3K
  • Earning Date
  • ATYR 08-12-2025
  • VPG 08-05-2025
  • Dividend Yield
  • ATYR N/A
  • VPG N/A
  • EPS Growth
  • ATYR N/A
  • VPG N/A
  • EPS
  • ATYR N/A
  • VPG 0.23
  • Revenue
  • ATYR N/A
  • VPG $297,480,000.00
  • Revenue This Year
  • ATYR $960.85
  • VPG N/A
  • Revenue Next Year
  • ATYR $1,283.47
  • VPG $6.38
  • P/E Ratio
  • ATYR N/A
  • VPG $122.77
  • Revenue Growth
  • ATYR N/A
  • VPG N/A
  • 52 Week Low
  • ATYR $1.48
  • VPG $18.57
  • 52 Week High
  • ATYR $5.98
  • VPG $35.11
  • Technical
  • Relative Strength Index (RSI)
  • ATYR 55.98
  • VPG 59.87
  • Support Level
  • ATYR $4.78
  • VPG $26.99
  • Resistance Level
  • ATYR $5.50
  • VPG $28.56
  • Average True Range (ATR)
  • ATYR 0.37
  • VPG 1.03
  • MACD
  • ATYR -0.09
  • VPG 0.12
  • Stochastic Oscillator
  • ATYR 36.12
  • VPG 83.06

About ATYR aTyr Pharma Inc. Common Stock

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

About VPG Vishay Precision Group Inc.

Vishay Precision Group Inc manufactures and markets sensors, and sensor-based measurement systems, as well as specialty resistors and strain gages based on proprietary technology. The company provides precision products and solutions, many of which are designed-in by customers, specializing in the growing markets of stress, force, weight, pressure, and current measurements. The company reports in three product segments: Sensors segment, Weighing Solutions segment, and Measurement Systems segment. It has a business presence in the United States and other countries. It generates the maximum of its revenue from the United States.

Share on Social Networks: